The researchers found that this treatment was beneficial in reducing pain while also improving quality of life. “Medical cannabis treatment with the Syqe Inhaler demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects in a cohort of patients with chronic pain, using just a fraction of the amount of MC [medical cannabis] compared with other modes of delivery by inhalation. These outcomes were accompanied by a lower rate of AEs [adverse events] and almost no AE reports during a long-term steady-state follow-up. Additional follow-ups in a larger population is warranted to corroborate our findings,” the authors concluded.
The NBA champion and New York Knick will premier his new flower brand at Torches…
By: LMC Legacy to licensed is the motto for authentic New York brands entering the…
Vlad Bautista began his cannabis empire in Harlem's Sugar Hill. Nearly 30 years later, his…
Cannabis terpenes are the compounds responsible for the aromatic profile of each strain; they are…
Authoritarians cannot let go of the value that keeping the most widely used illicit substance…
No need to wait until May—April showers bring dank flowers for every strain. A big…